May 2018

By Dennis Thompson HealthDay Reporter WEDNESDAY, May 16, 2018 (HealthDay News) — Less appears to be more when it comes to treating epilepsy with the marijuana extract cannabidiol, a new clinical trial suggests. Patients taking a 10-milligram (mg) daily dose of pharmaceutical grade cannabidiol (CBD) experienced nearly as great a reduction in seizures as patients […]

Local Headlines Copyright 2018 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Copyright 2018 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. “);b.ajax({type:”GET”,url:c}).done(function(h){var i=b(h);d.empty();d.append(i)}).fail(function(){d.append(“ Oops. Something went wrong. Please wait a… read more at: http://www.nbc4i.com/news/local-news/cannabis-derived-treatment-shows-significant-seizure-reduction-in-nationwide-children-s-study/1183520100

Cannabidiol (CBD), a compound derived from the cannabis plant that does not produce a “high” and has been an increasing focus of medical research, was shown in a new large-scale, randomized, controlled trial to significantly reduce the number of dangerous seizures in patients with a severe form of epilepsy called Lennox–Gastaut syndrome. In the new […]

– First dose-ranging study comparing pharmaceutical formulation of cannabidiol to placebo as add-on therapy in Lennox-Gastaut syndrome, a rare, severe and difficult to treat form of childhood-onset epilepsy – – Both doses significantly reduced drop seizure frequency in patients with poor seizure control despite the use of multiple anti-epileptic drugs – LONDON and CARLSBAD, Calif., May 16, […]

By Brett Taylor and Amy Alderfer May 9, 2018, 1:26 PM EDT Law360 (May 9, 2018, 1:26 PM EDT) — Legalization of marijuana has been a popular idea in recent years, with 30 states and the District of Columbia having laws that legalize marijuana in some form. However, under federal law, marijuana is a Schedule […]

Dravet syndrome (DS), also known as epilepsy with polymorphic seizures and polymorphic epilepsy in infancy (PMEI), is a severe and rare genetic dysfunction of the brain (epileptic encephalopathy). It usually begins in first year of life and remains throughout lifetime. Children suffering from dravet syndrome suffer from different type of seizures namely, myoclonic seizures, tonic-clonic […]

Dravet syndrome (DS), also known as epilepsy with polymorphic seizures and polymorphic epilepsy in infancy (PMEI), is a severe and rare genetic dysfunction of the brain (epileptic encephalopathy). It usually begins in first year of life and remains throughout lifetime. Children suffering from dravet syndrome suffer from different type of seizures namely, myoclonic seizures, tonic-clonic […]

Dravet syndrome (DS), also known as epilepsy with polymorphic seizures and polymorphic epilepsy in infancy (PMEI), is a severe and rare genetic dysfunction of the brain (epileptic encephalopathy). It usually begins in first year of life and remains throughout lifetime. Children suffering from dravet syndrome suffer from different type of seizures namely, myoclonic seizures, tonic-clonic […]

High and wild—that is how the cannabis plant has grown in India. But, its uses have not been restricted to those two words. Though many farmers in the upper Himalayan reaches have grown the weed for its recreational use, women of Shauka and Kuthalia Bora tribes in Uttarakhand’s Kumaon, Pithoragarh and Almora districts have been […]

Staying drug-free is a constant battle for abstinent addicts. This struggle is made more difficult when former-addicts find themselves in drug-related settings, experience stress or higher levels of anxiousness. Many struggle to control their impulses when offered an addictive drug like alcohol or cocaine. Weiss and his research associate Gustavo Gonzalez-Cuevas set out to test […]

Insys Therapeutics’ Phase 2 trial to evaluate the safety and effectiveness of its cannabidiol (CBD) oral solution in pediatric patients with Prader-Willi syndrome (PWS) will soon begin recruiting participants. More information about the study and dates of enrollment will be announced on the clinical trial’s official webpage, found here (NCT02844933). The Insys announcement also recognizes May as PWS Awareness […]

BOISE, Idaho – The Food and Drug Administration is one step closer to approving a prescription CBD oil. Participants in an Idaho case study may have played a role in the decision-making process.  A panel of federal advisers unanimously voted last week to recommend the approval of the Epidiolex, the first prescription cannabidiol medicine, to […]